VTYX
Ventyx Biosciences Inc
A clinical-stage biopharmaceutical company developing small-molecule therapies for inflammatory and autoimmune diseases, including a potential oral treatment for ulcerative colitis and Crohn's disease. Founded by biotech entrepreneur and named for the Ventyx of Greek mythology. Note: The grounding search service was unavailable (HTTP 502) during this attempt, so this description could not be verified against web sources and should be treated with caution.
CUSIP: 92332V107HealthcareUS1 holder
Total Value
$150.56M
Total Shares
4.31M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
